This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Covx Technologies Ireland Limited, Covx Technology Ireland, Ltd.. Active years: 2009-2015.
Company Filing History:
2 out of 5 
2 out of 3 Years Active: 2009-2015
Title: Innovations of Jing-Yu Lai in Anti-Angiogenic Compounds
Introduction
Jing-Yu Lai is a notable inventor based in San Diego, CA, who has made significant contributions to the field of anti-angiogenic compounds. With a total of four patents to his name, Lai's work focuses on developing innovative solutions for disorders associated with abnormal angiogenesis.
Latest Patents
Lai's latest patents include groundbreaking inventions related to VEGF binding peptides. The first patent provides various uses of these peptides, including methods to treat disorders linked to abnormal angiogenesis. Additionally, this invention features VEGF peptides conjugated to antibodies, both alone and in conjunction with other anti-angiogenic molecules. The second patent reiterates the importance of VEGF binding peptides and their various applications in treating related disorders.
Career Highlights
Throughout his career, Jing-Yu Lai has worked with prominent companies such as Covx Technologies Ireland Limited and Covx Technology Ireland, Ltd. His expertise in the field has allowed him to contribute to significant advancements in medical treatments.
Collaborations
Lai has collaborated with notable professionals, including Curt William Bradshaw and Venkata Ramana Doppalapudi, enhancing the impact of his work through teamwork and shared knowledge.
Conclusion
Jing-Yu Lai's innovative contributions to anti-angiogenic compounds demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for disorders related to abnormal angiogenesis.